The Worldwide Autoimmune Disease Diagnostics Industry is Projected to Reach $7.1 Billion by 2027 at a 8.91% CAGR - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Sep 29, 2022--

The "Autoimmune Disease Diagnostics Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The Global Autoimmune Disease Diagnostics Market is projected to reach USD 7,169.73 million by 2027 from USD 4,294.85 million in 2021, at a CAGR 8.91% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

• The Americas Autoimmune Disease Diagnostics Market size was estimated at USD 1,527.67 million in 2021, is expected to reach USD 1,661.49 million in 2022, and is projected to grow at a CAGR of 8.90% to reach USD 2,548.86 million by 2027.
• The Asia-Pacific Autoimmune Disease Diagnostics Market size was estimated at USD 1,268.05 million in 2021, is expected to reach USD 1,388.74 million in 2022, and is projected to grow at a CAGR of 9.15% to reach USD 2,144.74 million by 2027.
• The Europe, Middle East & Africa Autoimmune Disease Diagnostics Market size was estimated at USD 1,499.11 million in 2021, is expected to reach USD 1,622.12 million in 2022, and is projected to grow at a CAGR of 8.72% to reach USD 2,476.12 million by 2027.

Market Segmentation & Coverage:

The report on autoimmune disease diagnostics identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making.

This market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the autoimmune disease diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• Localized Autoimmune Disease Diagnostics
• Systemic Autoimmune Disease Diagnostics

Indication:

• Addison Disease
• Celiac Disease
• Dermatomyositis
• Graves Disease
• Hashimoto Thyroiditis
• Multiple Sclerosis
• Myasthenia Gravis
• Pernicious Anemia
• Reactive Arthritis
• Rheumatoid Arthritis
• Sjogren syndrome
• Systemic Lupus Erythematosus
• Type I Diabetes

Test:

• Autoantibodies & Immunologic Test
  • Anti-cyclic Citrullinated Peptide
  • Antinuclear Antibody
  • C-reactive Protein
  • Erythrocyte Sedimentation Rate
  • Rheumatoid Factor
  • Thyroid Antibody Tests
    • T3
    • T3RU
    • T4
    • TSH
• Inflammatory Marker
• Routine Laboratory Test

Product:

• Consumable & Assay Kit
• Diagnostic Instrument

End User:

• Clinical Laboratory
• Hospital

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Abbott Laboratories
• AESKU.GROUP GmbH & Co. KG
• AstraZeneca PLC
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• BioAgilytix Labs
• Biogenuix Medsystems Private Limited
• bioMerieux SA
• EUROIMMUN Medical Laboratory Diagnostics AG
• Exagen Inc.
• F. Hoffmann-La Roche AG
• Hemagen Diagnostics, Inc.
• Novartis AG
• Pfizer Inc.
• Quest Diagnostics
• Sanofi S.A.
• SD BioSensor Inc.
• Siemens Healthineers AG
• SQI Diagnostics
• Thermo Fisher Scientific Inc.
• Trinity Biotech PLC
• Werfen Group

For more information about this report visit https://www.researchandmarkets.com/r/oh8300

View source version on businesswire.com:https://www.businesswire.com/news/home/20220929005389/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2022.